Jeff Yass’s BlackRock Health Sciences Trust II BMEZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$760K Sell
49,515
-35,272
-42% -$507K ﹤0.01% 8903
2026
Q1
$1.22M Sell
84,787
-14,741
-15% -$219K ﹤0.01% 7380
2025
Q4
$1.5M Buy
99,528
+23,434
+31% +$352K ﹤0.01% 6256
2025
Q3
$1.1M Buy
+76,094
New +$1.08M ﹤0.01% 7134
2025
Q2
Sell
-57,780
Closed -$861K 12678
2025
Q1
$861K Buy
57,780
+17,996
+45% +$282K ﹤0.01% 7634
2024
Q4
$573K Buy
39,784
+26,261
+194% +$406K ﹤0.01% 8333
2024
Q3
$214K Sell
13,523
-73,155
-84% -$1.15M ﹤0.01% 10336
2024
Q2
$1.33M Sell
86,678
-8,150
-9% -$124K ﹤0.01% 5920
2024
Q1
$1.55M Sell
94,828
-4,210
-4% -$66.4K ﹤0.01% 5922
2023
Q4
$1.45M Buy
99,038
+2,972
+3% +$41.5K ﹤0.01% 6083
2023
Q3
$1.38M Buy
96,066
+80,928
+535% +$1.26M ﹤0.01% 5912
2023
Q2
$249K Buy
+15,138
New +$247K ﹤0.01% 9824

Other funds holding BMEZ

Jeff Yass's BMEZ Position: Q2 2026 in Review

Jeff Yass reduced its BlackRock Health Sciences Trust II (BMEZ) stake by 42% in Q2 2026, selling an estimated $507K and leaving 49,515 shares worth $760K. The position accounts for ﹤0.01% of the portfolio, ranked #8903.

Jeff Yass first reported a position in BMEZ in Q2 2023 and has held it in 12 quarters since. The position peaked at $1.55M in Q1 2024. 88 funds tracked by Wall St. Rank hold BMEZ as of Q2 2026.

  • Jeff Yass held 49,515 shares of BlackRock Health Sciences Trust II worth $760K as of Q2 2026.
  • Jeff Yass sold 35,272 BlackRock Health Sciences Trust II shares in Q2 2026, an estimated $507K.
  • BlackRock Health Sciences Trust II made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #8903 holding.
  • Jeff Yass first reported a position in BlackRock Health Sciences Trust II in Q2 2023 and has held it in 12 quarters since.
  • Jeff Yass's BlackRock Health Sciences Trust II position peaked at $1.55M in Q1 2024.
  • 88 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust II as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.